Read more
For this issue, Dr. Michael Lim of Johns Hopkins and Dr. Isaac Yang of UCSF team up to deliver a packed issue on the latest developments in Immunotherapy. The issue covers hot topics such as immunostimulants, Passive Antibody Mediated Immunotherapy, Clinical Applications of A Peptide Based Vaccine, Challenges for Clinical Design of Immunotherapy Trials, The EGFRv3 Peptide Vaccine, Stem Cell Therapy and Dendritic Cell Vaccines, Dendritic Glioma Fusion Vaccine, Adoptive Cellular Immunotherapy, Virus Mediated Immunotherapy, and so much more.
About the author
Dr. Yang is an Associate Professor in the Department of Neurosurgery at UCLA. He has been awarded the AANS Tumor Investigator Award and the Exceptional Physician Award. Dr. Yang is a nationally recognized leader in neurosurgery and brain tumors, serving on both executive committees and editorial boards. He has published more than 100 publications, and has authored multiple book chapters and several textbooks, including a Service Minded Physician.Michael Lim, M.D. is a board certified interventional cardiologist with 20 years of and is Chief of the Cardiac Catheterization Lab at Hackensack University Medical Center. Prior to joining Hackensack Meridian Medical Group, Dr. Lim served as the Jack Ford Shelby Endowed Professor in Cardiology and Professor of Internal Medicine at Saint Louis University in St. Louis, Missouri. Dr. Lim has held the role of principal investigator on numerous clinical trials for conditions including mitral valve disease, cardiogenic shock and coronary artery disease. Since 1990, he has contributed more than 100 publications to medical literature, including more than 30 book chapters. He has also served as an invited faculty member at numerous national conferences.
